PATRICK G ENRIGHT
CIK 1253886 · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$925.70M
Companies
17
Total Filings
149
Lifetime Open-Market Net
-$89.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | Director | 3,602,475 | $34.26 | $123.42M | $32.53M | 11 | 2026-05-26 |
| MANE | Director | 2,407,752 | $96.07 | $231.31M | $18.27M | 1 | 2026-02-05 |
| JAZZ | Director | 21,379 | $230.56 | $4.93M | -$228.70M | 64 | 2026-01-08 |
| ZBIO | Director | 1,844,659 | $19.80 | $36.52M | $9.73M | 3 | 2025-10-14 |
| BIOA | Director | 1,310,589 | $18.04 | $23.64M | $7.20M | 2 | 2025-06-09 |
| Aptinyx Inc. (APTX) Delisted | Director | 3,451,746 | $0.06 | $210.6K | $3.19M | 14 | 2022-05-31 |
| Sierra Oncology, Inc. (SRRA) Delisted | 10%+ Owner | 5,611 | $54.99 | $308.5K | $0 | 1 | 2022-04-29 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 3,918,691 | $2.57 | $10.07M | $12.60M | 1 | 2020-10-22 |
| COLL | Director | 0 | $34.64 | $0 | $1.92M | 11 | 2020-10-14 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,007,225 | $4.00 | $8.03M | $40.00M | 1 | 2020-07-28 |
| 89bio, Inc. (ETNB) Delisted | 10%+ Owner | 2,600,877 | $14.84 | $38.60M | $48.80M | 2 | 2020-07-14 |
| Molecular Templates, Inc. (MTEM) Delisted | 10%+ Owner | 4,198,535 | $0.00 | $420 | $29.98M | 1 | 2019-11-27 |
| Axonics, Inc. (AXNX) Delisted | 10%+ Owner | 2,933,333 | $70.98 | $208.21M | $24.00M | 1 | 2018-11-02 |
| KALA | 10%+ Owner | 2,055,946 | $2.63 | $5.41M | $12.90M | 1 | 2017-07-27 |
| CORT | Director | 5,993,653 | $82.91 | $496.93M | -$43.10M | 26 | 2017-03-20 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | Director | 7,467,694 | — | — | $10.45M | 3 | 2016-03-31 |
| ESPR | Director | 1,119,256 | $3.15 | $3.53M | -$69.15M | 6 | 2015-05-18 |
Recent Filings · Page 4 of 15
149 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-04 | JAZZ | Exer (M) | +9,929 | $0 | EDGAR |
| 2020-10-22 | Eargo, Inc. (EAR) Delisted | Mixed | +11,756,073 | $12.60M | EDGAR |
| 2020-10-14 | COLL | Mixed | −170,098 | -$5.87M | EDGAR |
| 2020-10-02 | Aptinyx Inc. (APTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-23 | COLL | Other (J) | −6,021,437 | $0 | EDGAR |
| 2020-08-10 | JAZZ | Grant (A) | +2,705 | $0 | EDGAR |
| 2020-07-28 | Inozyme Pharma, Inc. (INZY) Delisted | Mixed | +11,277,516 | $40.00M | EDGAR |
| 2020-07-14 | 89bio, Inc. (ETNB) Delisted | Buy (P) | +436,360 | $12.00M | EDGAR |
| 2020-07-02 | Aptinyx Inc. (APTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-29 | COLL | Mixed | +7,840 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.